UK markets open in 7 hours 21 minutes
  • NIKKEI 225

    28,010.93
    -953.15 (-3.29%)
     
  • HANG SENG

    28,489.00
    -312.27 (-1.08%)
     
  • CRUDE OIL

    73.44
    -0.22 (-0.30%)
     
  • GOLD FUTURES

    1,784.30
    +1.40 (+0.08%)
     
  • DOW

    33,876.97
    +586.89 (+1.76%)
     
  • BTC-GBP

    22,875.12
    -2,747.88 (-10.72%)
     
  • CMC Crypto 200

    762.93
    -87.41 (-10.28%)
     
  • ^IXIC

    14,141.48
    +111.10 (+0.79%)
     
  • ^FTAS

    4,026.96
    +24.89 (+0.62%)
     

GCC Generic Injectables Market: Strong Growth Expected from 2021-2026

·4-min read

Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The GCC generic injectables market reached a value of US$ 469.5 Million in 2020. Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases and osteoporosis. A rise in the prevalence of various lifestyle diseases in the GCC region has catalyzed the demand for these injectables. The lower cost of these drugs as compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.

Market Drivers:

An increase in the emigrant population along with a rise in the cases of both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The resulting surge in the overall healthcare costs has boosted the demand for these injectables.

Moreover, upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers. Apart from this, the total number of manufacturers in the market is lower as compared to those in the oral generics segment.

This results in lower price erosion and significantly higher margins. Some of the other factors driving the market in this region include aging population, development of the private healthcare sector and improving standards of living. According to the estimates by the publisher, the GCC generic injectables market is expected to exhibit strong growth during 2021-2026.

Break up by Container Type:

  • Vials

  • Prefilled Syringes

  • Ampoules

  • Premix

  • Others

  • Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.

Break up by Therapeutic Area:

  • Oncology

  • Anaesthesia

  • Anti-infectives

  • Cardiovascular

  • Parenteral Nutrition

  • Others

Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.

Break up by Distribution Channel:

  • Hospitals

  • Clinics

  • Retail Pharmacy Stores

  • These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.

Regional Insights:

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

  • Bahrain

  • Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.

Competitive Landscape:

The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.

Key Questions Answered in This Report:

  • How has the GCC generic injectables market performed so far and how will it perform in the coming years?

  • What are the key regional markets in the GCC generic injectables industry?

  • What has been the impact of COVID-19 on the GCC generic injectables market?

  • What are the several therapeutic areas in the GCC generic injectables industry?

  • What are the major distribution channels in the GCC generic injectables industry?

  • What are the different container types in the GCC generic injectables industry?

  • What are the various stages in the value chain of the GCC generic injectables industry?

  • What are the key driving factors and challenges in the GCC generic injectables industry?

  • What is the structure of the GCC generic injectables industry and who are the key players?

  • What is the degree of competition in the GCC generic injectables industry?

  • What are the profit margins in the GCC generic injectables industry?

  • What are the key requirements for setting up a generic injectables manufacturing plant?

  • How are generic injectables manufactured?

  • What are the various unit operations involved in a generic injectables manufacturing plant?

  • What is the total size of land required for setting up a generic injectables manufacturing plant?

  • What are the machinery requirements for setting up a generic injectables manufacturing plant?

  • What are the raw material requirements for setting up a generic injectables manufacturing plant?

  • What are the packaging requirements for generic injectables?

  • What are the transportation requirements for generic injectables?

  • What are the utility requirements for setting up a generic injectables manufacturing plant?

  • What are the manpower requirements for setting up a generic injectables manufacturing plant?

  • What are the capital costs for setting up a generic injectables manufacturing plant?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 GCC Generic Injectables Market

6 Market Performance by Key Regions

7 Market Performance by Container Type

8 Market Performance by Therapeutic Area

9 Market Performance by Distribution Channel

10 Competitive Landscape

11 Generic Injectable Manufacturing Process

12 Project Details, Requirements and Costs Involved

13 Key Player Profiles

For more information about this report visit https://www.researchandmarkets.com/r/n2j1c0

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting